BOLD (Boundless Bio) Price-to-Operating-Cash-Flow : (As of May. 30, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Price-to-Operating-Cash-Flow?

As of today (2025-05-30), Boundless Bio's share price is $1.10. Boundless Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-2.68. Hence, Boundless Bio's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Boundless Bio's Price-to-Operating-Cash-Flow or its related term are showing as below:

BOLD's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.1
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Boundless Bio's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $-0.65. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-2.68.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -29.20% per year.

During the past 4 years, Boundless Bio's highest 3-Year average Operating Cash Flow per Share Growth Rate was -29.20% per year. The lowest was -29.20% per year. And the median was -29.20% per year.

Boundless Bio Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Boundless Bio's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Price-to-Operating-Cash-Flow Chart

Boundless Bio Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Boundless Bio Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Boundless Bio's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Boundless Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boundless Bio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Boundless Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Boundless Bio's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Boundless Bio Price-to-Operating-Cash-Flow Calculation

Boundless Bio's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.10	/	-2.682
	=

Boundless Bio's Share Price of today is $1.10.
Boundless Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.68.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Boundless Bio Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Boundless Bio's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Boundless Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

10955 Alexandria Way, Suite 100, San Diego, CA, USA, 92121

Website

https://www.boundlessbio.com

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.